Navigation Links
3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results
Date:2/20/2008

- Q4 2007 net revenues grew 29.8%, as compared to Q4 2006, to RMB45.7

million (US$6.3 million)

- Q4 2007 net income grew 152.2%, as compared to Q4 2006, to RMB17.9

million (US$2.5 million) - 2007 fiscal year net revenues increased 41.0% year-over-year to RMB180.2

million (US$24.7 million) - 2007 fiscal year net income grew 167.4% year-over-year to RMB81.5 million

(US$11.2 million)

SHENYANG, China, Feb. 20 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) (''3SBio'' or ''the Company''), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2007.

Fourth Quarter 2007 Financial Highlights:

-- Total net revenues increased 29.8% over the fourth quarter 2006 to

RMB45.7 million (US$6.3 million).

-- Net revenue from our flagship injectable recombinant human

erythropoietin products, or EPO products, marketed under our EPIAO

brand, increased 14.7% over the fourth quarter 2006 to RMB29.8 million

(US$4.1 million).

-- Net revenue from our protein-based therapeutic recombinant human

thrombopoietin products, or TPO products, marketed under our TPIAO

brand, increased 99.3% over the fourth quarter 2006 to RMB11.7 million

(US$1.6 million).

-- Operating income decreased 29.6% compared to the fourth quarter 2006

to RMB6.1 million (US$0.8 million)

-- Net income increased 152.2% over the fourth quarter 2006 to RMB17.9

mi
'/>"/>

SOURCE 3SBio Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. 3SBio Inc. Announces Change to the Board of Directors
2. 3SBio Inc. Schedules 2007 Fourth Quarter and Full Year Earnings Release on Wednesday, February 20, 2008
3. 3SBio Inc. to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
4. 3SBio Inc. Announces Appointment of Kevin Sow Peng Teo as Chief Financial Officer
5. 3SBio Inc. To Present at the 19th Annual Piper Jaffray Health Care Conference
6. 3SBio Inc. Schedules 2007 Third Quarter Earnings Release On Tuesday, November 13, 2007
7. 3SBio Inc. to Hold Annual General Meeting
8. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
9. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
10. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
11. Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014  Next month, executives from ... three key industry events beginning with Patient-Centered Clinical Trials ... in Boston , September 4-5. Patient recruitment ... and Aaron Fleishman will share insights on the ... a variety of tactics – from media to mobile apps ...
(Date:8/28/2014)... new work by a Florida State University research team ... take your temperature, emit white light, and convert photon ... looks like a butterfly. , Biwu Ma, associate professor ... the FAMU-FSU College of Engineering, created the molecule in ... to discover that his creation has many other unique ...
(Date:8/28/2014)... PrimeSource Building Products, Inc., a leading ... to support their communication needs with the ... conferencing platform GlobalMeet powered by SoundConnect. The solution ... SoundConnect delivers award winning “results driven” business class ... be utilizing GlobalMeet powered by SoundConnect ...
(Date:8/27/2014)... 2014 Green & Grow Inc. (GGI) ... funding and secured Otter Capital as a significant new ... commercialization of GGI’s Agriplier™ technology, building on recent compelling ... “Since our first meeting, we have been impressed with ... space,” said Alan Sobba, President and CEO of GGI. ...
Breaking Biology Technology:BBK Worldwide Leads Sessions at Key September Events 2Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices 2PrimeSource Chooses SoundConnect as Collaboration Provider 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 3
... LINCOLN, Neb., Aug. 20 LI-COR announces its second,webinar ... in In Vivo Imaging: Near Infrared Optical Imaging of ... CDT., Near-infrared (NIR) fluorescence offers dramatic benefits for ... depth of penetration and,decreased autofluorescence and light scatter that ...
... 20 MedPredict, a global,provider of pharmaceutical competitive ... providing critical strategic insight for pharma,and biotech companies ... sclerosis,(MS) therapies., Biogen/Elan,s Tysabri has been under ... a rare and potentially fatal brain disease,associated with ...
... Joseph F. Finn, Jr.,C.P.A. ("Finn"), Assignee of the assets ... today that all pharmaceutical,intellectual property will be sold at ... of the pieces of intellectual property for sale is ... of a,branded drug that currently has more than $2 ...
Cached Biology Technology:LI-COR August 27th On-Line Webinar Introduces New Approach to Small Animal In Vivo Imaging 2Expert Neurology Panel Weighs Impact of New Reports of PML in Multiple Sclerosis Patients on Tysabri 2Spherics, Inc. Successful Bidder May Make MHRA Submission 2
(Date:8/28/2014)... Research Careers) Program has announced the travel award recipients ... 18 22, 2014 in San Diego, California. ... students, post doctorates and scientists from underrepresented groups into ... encourage the participation of young scientists at the American ... 16 awards totaling $29,600., The FASEB MARC Program is ...
(Date:8/28/2014)... The support of peer groups and clinicians ... programs, according to recent University of Georgia research. ... the Athens-Clarke County area determined that role models ... of mothers of infants. , "Mothers who received ... at breastfeeding," said study co-author Alex Anderson, an ...
(Date:8/28/2014)... FASEB MARC (Maximizing Access to Research Careers) ... the American College of Sports Medicine,s Conference on ... in Miami, Florida. These awards are meant ... and scientists from underrepresented groups into the mainstream ... the participation of young scientists at the American ...
Breaking Biology News(10 mins):Breastfeeding study shows need for effective peer counseling programs 2
... Durham, NC The most toxic, brightly colored members of ... says a new study. So-named because some tribes use ... frogs of the Amazon jungle are well known for their ... forest frogs serve to broadcast their built-in chemical weapons: ...
... project to develop and evaluate new tools to control ... a five year, 12 million project involving sixteen partners ... Seventh Framework programme. Because malaria is transmitted by ... disease. Wide scale use of insecticides on bednets ...
... laboratory discoveries into daily clinical practice is important, but ... to the laboratory, to further explore and explain clinically ... basic researchers to understand and address clinical challenges and ... integrate and use new technologies. The key towards ...
Cached Biology News:Fitness tests for frogs? 2€12 million ($16.9 million) project to develop new tools for malaria control 2
Eppendorf tube holder, for Tube rack 175 x 12 mm, 100. Category: Chromatography Systems & Accessories, Systems....
... Alkaline Phosphatase, Calf Intestinal (CIAP), catalyzes ... RNA, and ribo- and deoxyribonucleoside triphosphates. This ... religation of linearized cloning vector DNA by ... may also be used for the dephosphorylation ...
Agarose, pulse field, 100 g. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1800 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Molecular Biological Resources has extensive abilities cloning and expression of prokaryotic and eukaryotic proteins. Please contact lloconne@molbiores.com to discuss your project. Contact lloconne@...
Biology Products: